Blood carbon dioxide tension and risk in pulmonary arterial hypertension. (1st November 2020)

• Record Type: Journal Article
• Authors: Harbaum, Lars; Fuge, Jan; Kamp, Jan C.; Hennigs, Jan K.; Simon, Marcel; Sinning, Christoph; Oqueka, Tim; Grimminger, Jan; Olsson, Karen M.; Hoeper, Marius M.; Klose, Hans
• Is Part Of: International journal of cardiology. Volume 318(2020)
• Page Start: 131
• Page End: 137
• Publication Date: 2020-11-01
• Subjects: Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2020.06.069
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Low partial pressure of blood carbon dioxide (Pa CO2 ) is common in patients with pulmonary arterial hypertension (PAH) and may inform on clinical outcomes. We investigated whether Pa CO2 measurements could provide prognostic information in addition to standard risk assessment in this group of patients. Methods: We conducted a retrospective observational cohort study on patients with newly diagnosed idiopathic, heritable or drug/toxin-induced PAH recruited from two European centres. Arterialised capillary blood gas analyses at diagnosis and follow-up were incorporated into standard risk assessment strategies and related to outcomes, defined as lung transplant or death. C statistics from receiver-operated characteristics and Cox regression models were used to assess the predictive value of models with and without Pa CO2 measurements. Unsupervised clustering was applied to assess the relation of Pa CO2 to haemodynamic and pulmonary function variables. Results: Low Pa CO2 measured at diagnosis and follow-up was significantly associated with inferior outcomes in 204 patients with PAH. Pa CO2 provided prognostic information independent of established non-invasive variables. Integrating Pa CO2 in risk strata improved C statistics of non-invasive and mixed invasive/non-invasive models, and revealed more accurate outcome estimates in regression models. Pairwise correlation and unsupervised cluster analyses supported a link between Pa CO2 and haemodynamic variables, particularly with cardiac output, in PAH. Conclusions: Measuring Pa CO2 at diagnosis and during follow-up in patients with PAH provided independent prognostic information and has the potential to improve current risk assessment strategies. Highlights: Pa CO2 was prognostic in patients with PAH at diagnosis and follow-up. Pa CO2 was an independent non-invasive prognostic parameter. Integration of Pa CO2 improved contemporary risk assessment strategies. Pa CO2 related to hemodynamic but not pulmonary function parameters.